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ABSTRACT 
 
 
 
 
The extracellular matrix for connective tissues displays an abstruse alloy of 
changeable members of various protein families describing structural validity and 
different physiological functions. The most important component of extracellular matrix 
is collagen. Collagens’ large family in humans is consisting of at least 27 members 
(described as being type I to XXVII) with 42 distinguished polypeptide chains. Collagen 
type I is the most plentiful and extensively expressed collagen in human which is 
comprising of 2 α1 chains and one α2 chain and their gens are located at the different 
loci,COL1A1 and COL1A2 respectively. Mutation at these loci causes various 
connective tissue disorders such as Osteogenesis Imperfecta(OI). Osteogenesis 
Imperfecta (OI) or Vrolik's syndrome is a heterogeneous group of inherited conditions 
which has different types but, Type III is individualized among the other classifications 
because this type is the "Progressive Deforming" type. This study reports a comparative 
investigation on a short sequence of α1 and α2 chains near the c-terminal positions by 
the means of mutated and normal cases. Our focus in this study was on two point 
mutations near the end of each chain which in α1 are Gly973Ser & Gly1009Ser and in 
α2 are Gly997Asn & Gly1006Ala by extracting our desired parts of α1&α2 sequences 
from UniProt and modeling them by using EsyPred3D with applying the most identical 
pdb file obtained from rcsb & BLAST as template. After visualization and doing 
mutation by PyMOL, the differences in their sequence have been investigated by 
Jalview. Our obtained results from simulation of normal and mutated structures of 
α1&α2 by GROMACS software demonstrated that substitution of Gly by Ser in α1 and 
by Ala in α2 affected on the function of protein, on the other hand, substitution of Gly 
by Asn in α2 effected on the structure of protein. 
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ABSTRAK 
 
 
 
 
Matriks extracellular (atau matriks luar sel) untuk tisu penghubung 
mempamerkan ahli aloi berubah yang sukar difahami serta terdiri daripada pelbagai 
kumpulan protein yang menerangkan kesahihan struktur dan fungsi fisiologi yang 
berbeza. Kolagen jenis I adalah kolagen terbanyak yang diekspress secara meluas dalam 
badan manusia dan ia terdiri daripada beberapa rantai 2 α1 dan satu rantai α2 serta. 
Mutasi pada lokus ini menyebabkan pelbagai gangguan dalam tisu penghubung seperti 
Osteogenesis Imperfecta (OI). Osteogenesis Imperfecta (OI) atau Vrolik sindrom adalah 
satu kumpulan heterogeneous yang diwarisi dan terdiri daripada pelbagai jenis tetapi, 
Jenis III telah diklasifikasikan sebagai individu berbanding dengan jenis-jenis yang lain 
kerana ia adalah jenis yang "Progresif  Deformasi" atau “Progresif yang mencacatkan 
bentuk”. Kajian ini melaporkan tentang penyelidikan mengenai urutan singkat rantaian 
α1 dan α2 yang berada berhampiran c-terminal dan dikaji dengan membuat 
perbandingan antara kes mutasi dan normal. Fokus kajian ini adalah pada dua titik 
mutasi yang berhampiran dengan hujung setiap rantaian di mana, pada α1 adalah 
Gly973Ser & Gly1009Ser dan α2 adalah Gly997Asn & Gly1006Ala, dengan 
mengektrak bahagian urutan α1 & α2 yang dikehendaki dari UniProt dan membina 
model melalui EsyPred3D dengan menggunakan fail pdb yang sama (diperolehi 
daripada RCSB & BLAST) sebagai template. Selepas visualisasi dan melakukan mutasi 
melalui PyMOL, perbezaan dalam urutan telah dikaji denagn menggunakan Jalview. 
Hasil yang diperolehi dari simulasi struktur normal dan mutasi daripada α1 & α2 melalui 
perisian GROMACS menunjukkan bahawa penggantian GLY kepada SER dalam α1 dan 
kepada ALA dalam α2 menjejaskan fungsi protein manakala penggantian GLY kepada 
Asn dalam α2 memberi efek kepada struktur protein. 
 
viii 
 
 
TABLE OF CONTENT 
 
 
 
 
CHAPTER                                                      TITLE                                            PAGE 
TITLE PAGE                                                                                      II 
DECLARATION OF ORIGINALITY AND 
EXCLUSIVENESS                                                                            III 
DEDICATION                                                                                    IV 
ACKNOWLEDGEMENTS                                                               V 
ABSTRACT                                                                                        VI 
ABSTRAK                                                                                          VII 
TABLE OF CONTENTS                                                                  VIII 
LIST OF TABLES                                                                             XII 
LIST OF FIGURES                                                                           XIII 
LIST OF FORMULA                                                                        XVI 
LIST OF ABBREVIATIONS                                                           XVII 
 1 INTRODUCTION                                                                                 1 
  1.1  Background                                                                                      1 
  1.2  Problem Statement                                                                           3 
  1.3  Aim of study                                                                                    4 
  1.4  Objectives                                                                                        4 
  1.5  Scope of Study                                                                                 5 
  1.6  Significant of study                                                                          5 
 2 LITERATURE REVIEW                                                                    6 
  2.1  ECM(Extra Cellular Matrix)                                                            6 
  2.2  Collagen                                                                                           7 
ix 
 
  2.3  The importance of collagen research                                               8 
  2.4  Basic structural module of collagen                                                 9 
  2.5  Different types of collagen and related diseases                             14 
  2.6  Collagen type I                                                                                18 
         2.6.1  Collagen type I structure                                                       18 
         2.6.2  The genes encoding type I collagen                                      19 
         2.6.3  The collagen type I amino acid numbers                              19 
         2.6.4  The collagen type I DNA sequence numbers                        21 
         2.6.5  Mutation of COL1A1 and COL1A2                                      21 
  2.7  Osteogenesis Imperfecta (OI)                                                          22 
  2.8  Different types of Osteogenesis Imperfecta                                    24 
  2.9  Various types of mutations recognized in                                       26 
       Osteogenesis Imperfecta  
           2.9.1  Point mutations are common                                               27 
  2.10  Osteogenesis Imperfecta type III                                                   29 
           2.10.1  The symptoms of OI type III                                             29 
 3 MATERIAL AND METHOD                                                             31 
  3.1  Experimental design                                                                        31 
  3.2  Identification of collagen type I sequence in human                       33 
         3.2.1  UniProt (Universal Protein Resource)                                   33 
         3.2.2  FASTA format                                                                       34 
  3.3  Finding PDB file for collagen type I                                               35 
  3.4  BLAST sequence of collagen type I with PDB file                        36 
  3.5  Prediction and modeling the α1 chain                                             37 
         3.5.1  EsyPred 3D                                                                            37 
  3.6  Visualization of α1 and α2 structures                                              38 
         3.6.1  PyMOL                                                                                  38 
  3.7  Doing mutation                                                                                38 
  3.8  Multiple Sequence Alignment (MSA) analysis                               39 
  3.9  Simulation the structures of α1 and α2 chains                                 40 
         3.9.1  GROMACS                                                                           40 
x 
 
  3.10  Comparison of normal and mutant structures of α1                     41 
                                 and α2 chains           
  3.10  3.10.1  RMSD                                                                               42 
           3.10.2  RMSF                                                                                42 
 4 RESULTS AND DISCUSSION                                                          44 
  4.1  Identification of collagen type I sequence in human                      44 
        4.1.1  Getting the FASTA format of α1 and α2                               44 
  4.2  Getting the PDB file for human type I collagen                             47 
  4.3  Blast sequence of collagen type I                                                   47 
        4.3.1  Blast of α1 chain                                                                    47 
        4.3.2  Blast of α2 chain                                                                    49 
  4.4  Homology modeling of α1 and α2 chains                                       50 
         4.4.1  Modeling the α1 chain                                                          50 
       4.4.1  Modeling the α2 chain                                                          51 
  4.5  Visualization the structures                                                             51 
         4.5.1  Visualization the α1 structure                                               51 
                               4.5.1  Visualization the α2 structure                                               52 
  4.6  Doing mutation                                                                               53 
         4.6.1  Doing mutation in α1 chain                                                  54 
                               4.6.2  Doing mutation in α2 chain                                                  55 
  4.7  Multiple sequence alignment                                                          57 
  4.8  Molecular dynamics simulation (MDS)                                         59 
         4.8.1  MSD of α1 (930-1050)                                                         59 
                   4.8.1.1  MSD of α1m1                                                          60 
                                         4.8.1.2  MSD of α1m2                                                          60 
         4.8.2  MDS of α2 (930-1050)                                                         63 
                   4.8.2.1  MSD of α2m1                                                          64 
                                         4.8.2.2  MSD of α2m2                                                          65 
  4.9  Visualization of effects of mutations on 3D structurs                    69 
 5 CONCLUSION                                                                                    72 
  5.1  Conclusion                                                                                      72 
xi 
 
  5.2  Further work                                                                                   74 
REFERENCES                                                                                                            76 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
xii 
 
 
LIST OF TABLES 
 
 
 
 
TABLE NO.                                              TITLE                                                   PAGE    
2.1  Different types of collagen in vertebrate as they belong                        17 
                        to the major collagen families  
2.2  The domains and the number of their amino acids in                             20  
                         type I collagen 
2.3  Historical investigation of osteogenesis imperfect                                 24 
2.4  Various types of Osteogenesis Imperfecta                                             25 
3.1  Different types of amino acids and their codes                                      35 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
xiii 
 
 
LIST OF FIGURES 
 
 
 
 
FIGURE NO.                                          TITLE                                                    PAGE 
2.1  a) Conversion of Proline amino acid to hydroxyproline                       11 
                      . b) Conversion of Lysine amino acid to hydroxylisine 
2.2  a) this diagram showing the three left handed helix with                      12 
                         3 residues. The position 1, 4, 7 are just accumulated by 
                         GLY residues in all chains. The other two positions 2,3 
                        ,5,6 can be accumulated by other amino acids.(b). The  
                        collagens’ modified coiled-coiled triple helical structure  
                        which has 3.33 residues per turn.+36ᵒ is relating to the  
                        twist folding of each helix.by rotation of -108ᵒ, the neighboring 
                        chains  are related together 
2.3  a) stick accepted diagram of triple helical structure for                        13 
                         collagen with inter chain hydrogen bond. B) Ball accepted 
                        diagram of triple helical structure for collagen with inter 
                        chain hydrogen bond. Each chain has been shown with  
                        different color 
2.4  Molecular structure of fibrillar collagens and the different                   14 
                        subdomains such as the cleavage sites for N- and 
                        C-procollagenases (is related to type I collagen) 
 
 
 
 
 
xiv 
 
2.5  Map of point mutations in COLIAI(top) and COLIA2                          28 
                        (bottom) which shows substitutions for glycine within  
                         the triple helical domain of the al(I) and a2(I) chains, respectively 
                      . The location of each point mutation is demonstrated along the 
            chain. The substituting residue is listed on the left and thnumber 
            of the substituted glycine is listed along the line. The triple helix 
            contains 1014 amino acids and the first glycine is represented as 
            residue number 1. The phenotype of each mutation is denoted 
            below the mutation 
2.6  Adults with Osteogenesis Imperfecta. The pointed one is refer to         30 
                        Osteogenesis Imperfecta type III 
3.1  Overall insights in this study                                                                  32 
4.1  The FASTA formats of α1 and α2 chains and the selected                    46 
                        Sequences which have been applied for homology modeling 
4.2  a) alignment result. b) α1 chain has the most similarity with                 48 
                         chain A in 3HQV pdb file. 
4.3  a) alignment result. b) α2 chain has the most similarity with                 49 
                        chain B in 3HQV pdb file 
4.4  visualization of α1 structure                                                                   52 
4.5  visualization of α2 structure                                                                   53 
4.6  GLY substitutions in position 42 by SER                                              54 
4.7  GLY substitution in position 59 by SER                                                55 
4.8  GLY substitutions in position 68 by ASP                                              56 
4.9  GLY substitutions in position 77 by ALA                                             56 
4.10  The multiple sequence alignment of α1, α1 with first mutation             57 
                        and α1 with second mutation. The sequence is coloured  
                        according to the CLUSTAL colouring scheme and the 
                        consensus are displayed at the bottom. The pointed parts 
                        are related to the mutation sites 
 
 
xv 
 
4.11  The multiple sequence alignment of α2, α2 with first                             58 
                         mutation and α2 with second mutation. The sequence 
                         is coloured according to the CLUSTAL colouring scheme 
                         and the consensus are displayed at the bottom. The pointed 
                         parts are related to the mutation sites 
4.12  The plotted graphs of RMSD for α1, α1m1 (α1 with first mutation)      61 
                        and α1m2 (α1 with second mutation) 
4.13  The plotted graphs of RMSF for α1, α1m1 (α1 with first mutation)       62 
                        and α1m2 (α1 with second mutation) 
4.14  The plotted graphs of RMSD for α2, α2m1 (α2 with first mutation)      66 
                         and α2m2 (α2 with second mutation) 
4.15  The plotted graphs of RMSf for α2, α2m1 (α2 with first mutation)       67 
                        and α2m2 (α2 with second mutation) 
4.16  Gly substitution to Ser in α1 chain in position 42. a) wild type  b)         69 
                         mutated type 
4.17  Gly substitution to Ser in α1 chain in position 59. a) wild type  b)        70 
                         mutated type 
4.18  Gly substitution to Asn in α2 chain in position 68. a) wild type  b)       70                              
m                     mutated type 
4.19  Gly substitution to Ala in α2 chain in position 77. a) wild type  b)       71     
m                     mutated type 
 
 
 
 
 
 
 
 
xvi 
 
 
LIST OF FORMULA 
 
 
 
 
FORMULA NO                                      TITLE                                                     PAGE 
3.1   The rmsd formula in which R1 and R2 are position                 42 
                                    of Cα in model and real position respectively 
3.2   The rmsf formula in which T is the time over which                43 
                                    one wants to average, and  is the reference position  
                                    of particle i. Typically this reference position will 
                                     be the time-averaged position of the same particle i, i.e.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
xvii 
 
 
LIST OF ABBREVIATIONS 
 
 
 
 
Α1                                 Alpha 1 
A2                                 Alpha 2 
OI                                 Osteogenesis Imperfecta 
COL1A1                     Collagen type I alpha 1 
COL1A2                     Collagen type I alpha 2 
AD           Autosomal Dominant 
AR           Autosomal Recessive 
NCBI           National Center for Biotechnology Information 
PDB           Protein Data Bank 
BLAST          Basic Local Alignment Search Tool 
MSA           Multiple Sequence Alignment 
GROMACS          GROningrn Machine for Chemical Simulation 
A1m1           Alpha 1 with first mutation 
A1m2           Alpha 1 with second mutation 
A2m1           Alpha 2 with first mutation 
A2m2             Alpha 2 with second mutation 
ECM           Extra Cellular Matrix 
Aᵒ           Angstrom 
Cα                      Carbon alpha 
C-terminal          Carboxy-terminal 
N-terminal          Amino-terminal 
FACIT           Fibril Associate 
Kb           Kilo base pair 
cDNA           cyclic DNA 
xviii 
 
CM            Centimeter 
 
UniProt           Universal Protein resource 
UniRef           UniProt Refrence Cluster 
UniProtKB           UniProt Knowledgebase 
UniPrac           UniProt Archive 
UniMES           UniProt Metagenomic and Environmental Sequrnces 
SIB            Swiss Institute of Bioinformatics 
EBI            European Information Resource 
PIR            Protein Information Resource 
PIR-PSD           Protein Information Resource-Protein Sequence  
                                                        Database 
TrEMBL           Translated EMBL Nucleotide Sequence Data Library 
3D            3 Dimension 
NMR            Nuclear Magnetic Resonance 
ID            Identity Document 
DNA            Deoxyribonucleic Acid 
RNAse           Ribonucleic Acidase / Ribosomal Ribonucleic Aci 
RMSD            Root Mean Square Deviation 
RMSF            Root Mean Square Fluctuation 
A                                                     Alanine 
P            Proline 
B            Aspartate or Aspargine 
Q            Glutamine 
C            Cysteine 
R            Arginine 
D                                                     Aspartate 
S                       Serine 
E                       Glutamate 
T            Throeonine  
F                                                      Phenylalanine 
xix 
 
U             Selenocysteine 
G             Glycine 
V              Valine 
H             Histidine 
W             Tryptophane 
I             Isoleucine 
Y             Tyrosine 
K             Lysine 
Z             Glutamate or Glutamine 
L             Leucine 
M             Methionine 
N             Asparagine 
 
 
 
 
 
1 
 
 
CHAPTER 1 
 
 
 
 
INTRODUCTION 
 
 
 
 
1.1       Background 
 
 
            Collagen is a family of natural protein which can be found in animals, especially 
in the corpus and connective tissues of vertebrates (Müller, 2003). Collagen is the 
primary ingredient of the connective tissues, and is the most numerous types of protein 
found in mammals (Di Lullo, Sweeney, Körkkö, Ala-Kokko, & San Antonio, 2002). The 
elongated form of collagen fibrils accounted between 25% and 35% of the total amount 
of protein in the whole body of most animals. Collagen is the main constructive protein 
which organizes molecular cables that causes the strengthening in tendons and the vast 
sheets that compose the skin and interior organs. The addition of mineral crystals to 
collagen allows the formation of bones and teeth. Collagen found in skeleton protects 
the softer tissues and keeps them connected. 
            
 
          Although collagen possesses numerous irreplaceable obligatory functions, it is a 
protein with relatively simple structure. Collagen is made of  a triple helix which contain 
two identical α1 chains and an extra α2 chain with a only a small differences in its 
chemical combination to differentiate them (Orgel, San Antonio, & Antipova, 2011) , 
Each subunits of collagen molecule consisted of repeating triple motifs of Gly-X-Y  
2 
 
where the combination and presence of glycine amino acids in the structure of α chains 
and in each third amino acid allows the triple chains structure to self-assemble into a 
right handed triple helix which is then supported by hydrogen bonds and other ionic 
interactions (Hulmes, 2002).  
 
 
             So far, 28 different types of collagen molecules have been identified which 
types I to V are five common types. Some collagen types are continuously expressed, 
while the rest of them have limitation and each type has its own function. Collagen type 
1 is the most common type of collagen with the highest rate of expression in humans, 
making it the most extensively studied and characterized (Prockop, 1995). One of the 
most popular diseases which caused by mutation in collagen type 1 is Osteogenesis 
Imperfecta. 
         
 
Osteogenesis Imperfecta (OI), sometimes known as  brittle bone disease, or 
"Lobstein syndrome" (Kid)) is an inheritable bone disease. People who are afflicted with 
this disorder exhibit imperfect connective tissue due to the inability to produce and 
resulting in the shortage of the Type 1 collagen (Frank Rauch & Glorieux, 2004). This 
shortage is caused by the substitution of glycine amino acid to a bigger amino acid in the 
structure of triple helix, causing the formation of inflated regions inside of collagen 
structure, which effect both the intra molecular interaction and the neighboring 
molecular interactions (Gautieri, Uzel, Vesentini, Redaelli, & Buehler, 2009), This 
resulted in the formation of incorrect collagen structure between collagen fibrils during 
the formation of the bone and hydroxyapatite crystal and causing brittleness. 
 
 
In the case of genetic disorder, OI is caused by autosomal dominant disturbance 
of collagen type1. Most of this disorder are caused by mutations in both 
COL1A11and COL1A2 genes which encode the α1 and α2 chains  of type 1 collagen 
respectively (Drögemüller et al., 2009) 
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There are five types of Osteogenesis Imperfecta classification: 
a) Type I: AD (autosomal dominant), normal structure, blue sclerae, loss hearing, 
little deformity 
b) Type II: AD, long bone fractions, lethal form,  
c) Type III: AD & AR (autosomal recessive): server form, blue sclerae, loss 
hearing, oncoming deforming, shorter length, multiple breaks. 
d) Type IV: AD, softly server, variable short length, normal sclerae. 
e) Type V: caused by hypertrophic calluses.(Pagon et al., 2005) 
f) In this study, we focused on osteogenesis Imperfecta type III 
 
 
 
 
1.2 Problem Statement: 
 
 
Currently all the studies on the two classes of mutations in collagen reported in 
Osteogenesis Imperfecta are biochemical in nature. There are no detailed studies on the 
structural conformation and dynamics of the differences between the mutated and the 
wild type variants. 
 
 
 
 
1.3      The aim of study 
 
 
            The aim of this study is to investigate the possible effects of two point mutations 
on the tertiary structure of collagen type I as well as study the importance of positions of 
mutations on stability of protein and how they can be related to the symptoms of 
Osteogenesis Imperfecta type III. The data for this project will be based on experimental 
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results stored in bioinformatics databases such as the NCBI 
(http://www.ncbi.nlm.nih.gov), PDB (http://www.rcsb.org) and Gene bank 
(www.ncbi.nlm.nih.gov/genbank/). The data from these databases will then be analyzed 
using bioinformatics and visualization software such as BLAST 
(blast.ncbi.nlm.nih.gov/ ), PYMOL (www.pymol.org/) and the Jalview 
(www.jalview.org/) for multiple sequence alignment (MSA) then molecular dynamics 
simulation software such as GROMACS (www.gromacs.org/ ) to compare the stability 
and flexibility of the structures of normal and mutant types of α1 and α2 chains in 
collagen type I. The study aims to identify the differences in: sequences, structures, 
impact of mutations and stability of both chains in two mutant and normal type 
condition. 
 
 
 
 
1.4       Objectives 
 
 
The objectives of this study were: 
 
 
1. Determining the differences of the sequence, structure and conformation between 
the wild-type and mutant type structure. 
2. Structural and dynamics comparison and analysis of the implication of the 
differences in amino acid sequence in Osteogenesis Imperfecta Type III 
3. Investigate the impacts of two point mutations on stability of both α1 and α2 
chains of collagen type I in Osteogenesis Imperfecta type III. 
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1.5      Scope of Study 
 
 
The data for this project will be sourced by bioinformatics databases that store 
experimental information such as the NCBI (http://www.ncbi.nlm.nih.gov), the Protein 
Data Bank (www.rcsb.org), the UniProt (http://www.uniprot.org) and the Genbank 
(http://www.ncbi.nlm.nih.gov/genbank/). 
 
 
 
 
1.6      Significance of the study 
 
       
 This study will help identify and characterize the structural effects of point mutations 
and how it influences the structure and conformational changes via molecular dynamic 
simulations. The obtained output enables researchers to gain useful information regarding 
the collagen type I stability and its importance on various related diseases such as 
Osteogenesis Imperfecta type III. The findings of this study can provide information for 
research in collagen type I and its associated diseases.  
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